Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Carolyn Lefkowits

Concepts (166)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genital Neoplasms, Female
20
2023
100
6.390
Why?
Cancer Pain
6
2019
41
2.630
Why?
Palliative Care
15
2023
1032
2.260
Why?
Analgesics, Opioid
7
2021
1221
1.700
Why?
Pain Management
5
2021
421
1.450
Why?
Endometrial Neoplasms
5
2025
205
1.320
Why?
Medical Oncology
8
2022
345
1.280
Why?
Surgical Oncology
3
2019
30
1.260
Why?
Gynecology
7
2020
185
1.220
Why?
Hot Flashes
3
2013
92
1.060
Why?
Hospice Care
2
2023
230
0.740
Why?
Terminal Care
3
2023
284
0.710
Why?
Referral and Consultation
4
2017
881
0.670
Why?
Opioid-Related Disorders
5
2019
634
0.610
Why?
Communication
3
2020
980
0.540
Why?
Practice Guidelines as Topic
2
2016
1591
0.510
Why?
Perinatal Care
1
2016
61
0.470
Why?
Uterine Cervical Neoplasms
1
2019
269
0.470
Why?
Attitude of Health Personnel
3
2019
1219
0.450
Why?
Neoplasm Recurrence, Local
4
2025
1160
0.440
Why?
Neoplasms
2
2021
2954
0.420
Why?
Palliative Medicine
1
2014
24
0.410
Why?
Obstetrics and Gynecology Department, Hospital
1
2014
7
0.410
Why?
Oncology Service, Hospital
1
2014
15
0.410
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
139
0.400
Why?
Female
34
2026
79499
0.390
Why?
Cyclohexanecarboxylic Acids
1
2013
18
0.370
Why?
Ovarian Neoplasms
3
2026
604
0.370
Why?
Amines
1
2013
39
0.370
Why?
Ambulatory Care
2
2017
628
0.370
Why?
Cost of Illness
1
2014
323
0.360
Why?
Oncologists
3
2022
47
0.350
Why?
Complementary Therapies
1
2013
93
0.350
Why?
Needs Assessment
1
2014
404
0.340
Why?
Quality of Life
8
2026
3200
0.340
Why?
gamma-Aminobutyric Acid
1
2013
195
0.330
Why?
Humans
37
2026
146342
0.320
Why?
Analgesics
1
2013
230
0.320
Why?
Radiosurgery
2
2025
398
0.310
Why?
Guideline Adherence
1
2014
594
0.290
Why?
Hospice and Palliative Care Nursing
2
2022
115
0.290
Why?
Employment
2
2021
180
0.290
Why?
Education, Medical, Graduate
1
2014
568
0.290
Why?
Middle Aged
18
2025
36619
0.280
Why?
Prostatic Neoplasms
2
2013
972
0.280
Why?
Health Services Accessibility
1
2016
1107
0.270
Why?
Aged
14
2025
26432
0.260
Why?
Epidemics
2
2018
97
0.240
Why?
Neoplasm Grading
2
2025
313
0.240
Why?
Aged, 80 and over
6
2025
8391
0.230
Why?
Acceptance and Commitment Therapy
1
2026
36
0.220
Why?
Neoplasm Staging
3
2025
1488
0.220
Why?
Advance Care Planning
2
2020
244
0.210
Why?
Adult
13
2025
41087
0.200
Why?
Fatigue
1
2026
363
0.200
Why?
Medical Futility
1
2023
32
0.200
Why?
Breast Neoplasms
2
2013
2418
0.190
Why?
Gynecologic Surgical Procedures
2
2020
68
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2025
1998
0.180
Why?
Combined Modality Therapy
1
2025
1271
0.180
Why?
Patient Care Team
2
2019
701
0.170
Why?
Antineoplastic Agents, Hormonal
2
2013
196
0.170
Why?
Indoles
1
2025
511
0.170
Why?
Disease Management
1
2025
651
0.170
Why?
Brachytherapy
2
2019
132
0.160
Why?
Retrospective Studies
7
2022
17438
0.160
Why?
Cohort Studies
4
2021
6077
0.160
Why?
Ethics, Medical
1
2020
90
0.150
Why?
Enoxaparin
1
2020
68
0.150
Why?
Carcinoma, Endometrioid
1
2019
49
0.140
Why?
Hospices
1
2020
95
0.140
Why?
Infection Control
1
2020
174
0.140
Why?
Carcinosarcoma
1
2018
23
0.140
Why?
Pyridones
1
2020
210
0.140
Why?
Postoperative Care
1
2020
301
0.130
Why?
Uterine Neoplasms
1
2018
98
0.130
Why?
Disease-Free Survival
1
2019
778
0.130
Why?
Young Adult
5
2020
14330
0.130
Why?
Drug Prescriptions
1
2019
314
0.120
Why?
beta Catenin
1
2019
250
0.120
Why?
Drug and Narcotic Control
1
2016
24
0.120
Why?
Perinatal Death
1
2016
26
0.120
Why?
Survival Analysis
1
2020
1378
0.120
Why?
Cancer Care Facilities
1
2017
48
0.120
Why?
Preoperative Care
1
2019
396
0.120
Why?
Truth Disclosure
1
2016
51
0.120
Why?
Nausea
1
2016
111
0.120
Why?
Life Expectancy
1
2016
72
0.120
Why?
Pyrazoles
1
2020
517
0.120
Why?
Databases, Factual
2
2019
1493
0.110
Why?
Venous Thromboembolism
1
2020
332
0.110
Why?
Mood Disorders
1
2016
130
0.110
Why?
Self Efficacy
1
2019
418
0.110
Why?
Cancer Survivors
1
2020
348
0.110
Why?
Pneumonia, Viral
1
2020
387
0.110
Why?
Coronavirus Infections
1
2020
379
0.110
Why?
Anticoagulants
1
2020
746
0.110
Why?
Program Evaluation
1
2019
952
0.110
Why?
Outpatients
2
2017
440
0.100
Why?
Evidence-Based Medicine
1
2018
731
0.100
Why?
Physician-Patient Relations
1
2019
597
0.100
Why?
Patient Education as Topic
1
2019
770
0.100
Why?
Hospitalization
2
2014
2475
0.100
Why?
Stellate Ganglion
1
2013
8
0.100
Why?
Brain Neoplasms
1
2022
1325
0.090
Why?
Clonidine
1
2013
34
0.090
Why?
Symptom Assessment
1
2014
138
0.090
Why?
Societies, Medical
1
2016
907
0.090
Why?
Ovariectomy
1
2013
164
0.090
Why?
Tamoxifen
1
2013
193
0.090
Why?
Anxiety
1
2019
1125
0.090
Why?
Hormone Replacement Therapy
1
2013
107
0.090
Why?
Pandemics
1
2020
1707
0.090
Why?
Mass Screening
1
2020
1307
0.080
Why?
Drug Interactions
1
2013
405
0.080
Why?
Nerve Block
1
2013
114
0.080
Why?
Continuity of Patient Care
1
2014
298
0.080
Why?
Pain
1
2016
790
0.080
Why?
Data Collection
1
2014
650
0.080
Why?
Fellowships and Scholarships
1
2014
355
0.080
Why?
Multivariate Analysis
1
2014
1543
0.080
Why?
Treatment Outcome
1
2025
11821
0.080
Why?
Depression
1
2019
1575
0.070
Why?
Follow-Up Studies
2
2018
5439
0.070
Why?
Colorado
1
2019
4595
0.070
Why?
Logistic Models
1
2014
2126
0.070
Why?
Adolescent
4
2020
22557
0.070
Why?
Chemoradiotherapy
2
2020
238
0.070
Why?
Radiotherapy, Adjuvant
2
2019
222
0.070
Why?
Quality Improvement
1
2016
1354
0.060
Why?
Postoperative Complications
1
2020
3034
0.060
Why?
Curriculum
1
2014
1079
0.060
Why?
Severity of Illness Index
1
2014
2921
0.060
Why?
Randomized Controlled Trials as Topic
2
2026
1763
0.060
Why?
Surveys and Questionnaires
1
2019
6073
0.060
Why?
United States
3
2020
16136
0.060
Why?
Maintenance Chemotherapy
1
2025
41
0.060
Why?
Infant, Newborn
1
2016
6460
0.050
Why?
Risk Factors
2
2019
10921
0.050
Why?
Case-Control Studies
2
2021
3647
0.050
Why?
Cranial Irradiation
1
2022
85
0.040
Why?
Health Benefit Plans, Employee
1
2020
25
0.040
Why?
Unemployment
1
2020
43
0.040
Why?
Double-Blind Method
1
2025
2070
0.040
Why?
Resource Allocation
1
2020
45
0.040
Why?
Standard of Care
1
2020
81
0.040
Why?
Prospective Studies
2
2026
8123
0.040
Why?
DNA Polymerase II
1
2019
35
0.040
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
35
0.040
Why?
Microsatellite Instability
1
2019
57
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
111
0.030
Why?
PTEN Phosphohydrolase
1
2019
166
0.030
Why?
SEER Program
1
2018
233
0.030
Why?
Betacoronavirus
1
2020
288
0.030
Why?
Chemotherapy, Adjuvant
1
2018
429
0.030
Why?
Telemedicine
1
2026
966
0.030
Why?
Male
2
2013
73396
0.030
Why?
Tumor Suppressor Protein p53
1
2019
530
0.030
Why?
Critical Care
1
2020
706
0.030
Why?
Prognosis
1
2022
4351
0.020
Why?
Membrane Proteins
1
2019
1130
0.020
Why?
Predictive Value of Tests
1
2017
2113
0.020
Why?
Biomarkers, Tumor
1
2019
1339
0.020
Why?
Mutation
1
2019
4093
0.020
Why?
Risk Assessment
1
2017
3712
0.020
Why?
Pregnancy
1
2020
7230
0.020
Why?
Lefkowits's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)